Cytokines and Cardiomyocyte Death

References

• Colucci W S, Braunwald E. Pathophysiology of heart failure. Heart Disease: A Textbook of Cardiovascular Medicine, E Braunwald. WB Saunders, Philadelphia 1997; 394–420
   Google Scholar
• Colucci W S. Apoptosis in the heart. N Engl J Med 1996; 335: 1224–6
   PubMed Web of Science ®Google Scholar
• Anversa P, Kajstura J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol 1996; 11: 245–51
   PubMed Web of Science ®Google Scholar
• Levine B, Kalman J, Mayer L, Fillit H M, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 223: 236–41
   Google Scholar
• Wiedermann C J, Beimpold H, Herold M, Knapp E, Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol 1993; 22: 1897–901
   PubMedGoogle Scholar
• Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704–11
   PubMed Web of Science ®Google Scholar
• Szabolcs M, Michler R E, Yang X, et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation 1996; 94: 1665–73
   PubMed Web of Science ®Google Scholar
• Haywood G A, Tsao P S, von der Leyen H E, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996; 93: 1087–94
   PubMed Web of Science ®Google Scholar
• Cleveland J L, Ihle J N. Contenders in Fas/TNF death signaling. Cell 1995; 81: 479–82
   PubMed Web of Science ®Google Scholar
• Fraser A, Evan G. A license to kill. Cell 1996; 85: 781–4
   PubMedGoogle Scholar
• Lange G L, Schreiner G F. Immune mechanisms of cardiac disease. N Engl J Med 1994; 330: 1129–35
   PubMedGoogle Scholar
• Barry W H. Mechanisms of immune-mediated myocyte injury. Circulation 1994; 89: 2421–32
   PubMedGoogle Scholar
• Cohen M C, Cohen S. Cytokine function: a study in biologic diversity. Am J Clin Pathol 1996; 105: 589–98
   PubMed Web of Science ®Google Scholar
• Kelly R A, Bailigand J -L, Smith T W. Nitric oxide and cardiac function. Circ Res 1996; 79: 363–80
   PubMed Web of Science ®Google Scholar
• Gottlieb R A, Burleson K O, Kloner R A, Babior B M, Engler R L. Reperfusion injury indues apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621–8
   PubMed Web of Science ®Google Scholar
• Goldhaber J L, Kim K H, Natterson P D, Lawrence T, Yang P, Weiss J N. Effects of TNF-alpha on [Ca2+]i and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol 1996; 271: H1449–55
   PubMed Web of Science ®Google Scholar
• Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo J E. Tumor necrosis factor alpha and interleukin 1 beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183: 949–58
   PubMed Web of Science ®Google Scholar
• Smith C A, Farrah T, Goodwin R G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 1994; 76: 959–62
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Peritt D, Gerosa F. Acute induction and priming for cytokine production in lymphocytes. Cytokine Growth Factor Rev 1996; 7: 123–32
   PubMedGoogle Scholar
• Eppinger M J, Ward P A, Boiling S F, Deeb G M. Regulatory effects of interleukin-10 on lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 1996; 112: 1301–5
   PubMed Web of Science ®Google Scholar
• Chien K R. Genes and physiology: molecular medicine in genetically engineered animals. J Clin Invest 1996; 98(Suppl)S19–26
   Google Scholar
• Warwick-Oavies J, Lowrie D B, Cole P J. Selective deactivation of human monocyte functions by TGF-beta. J Immunol 1995; 155: 3186–93
   PubMedGoogle Scholar
• Haeffner A, Thieblemont N, Deas O, et al. Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappaB translocation in lipopolysaccharide-stimulated human monocytes. J Immunol 1997; 158: 1310–4
   PubMedGoogle Scholar
• Buerke M, Hurohara T, Skurk C, Nuss C, Tomaselli K, Lefer A M. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 1995; 92: 8031–5
   PubMed Web of Science ®Google Scholar
• Wolf M, Bohm S, Brand M, Kreymann G. Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells. Eur J Endocrinol 1996; 135: 729–37
   PubMed Web of Science ®Google Scholar
• Pennica D, King K L, Shaw K J, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertophy. Proc Natl Acad Aci USA 1995; 92: 1142–6
   PubMed Web of Science ®Google Scholar
• Sheng Z, Pennica D, Wood Wl, Chien K R. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 1996; 122: 419–28
   PubMed Web of Science ®Google Scholar
• Wollert K C, Taga T, Saito M, et al. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 1996; 271: 9535–45
   PubMed Web of Science ®Google Scholar
• Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown J H, Chien K R. Cardiotrophin-1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 1997; 272: 5783–91
   PubMed Web of Science ®Google Scholar
• Ikeda U, Kanbe T, Kawahara Y, Yokoyama M, Shimada K. Adrenomedullin augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Circulation 1996; 94: 2560–5
   PubMedGoogle Scholar
• Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 1996; 94: 1506–12
   PubMed Web of Science ®Google Scholar
• Hockenbery D M, Oltvai Z N, Yin X -M, Milliman C L, Korsmeyer S J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241–51
   PubMed Web of Science ®Google Scholar
• Yeh E TH. Life and death in the cardiovascular system. Circulation 1997; 95: 782–6
   PubMedGoogle Scholar
• Kerr J FR, Wyllie A H, Currie A R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–57
   PubMed Web of Science ®Google Scholar
• Carson D A, Ribeiro J M. Apoptosis and disease. Lancet 1993; 341: 1251–4
   PubMed Web of Science ®Google Scholar
• Majno G, Joris I. Apoptosis, oncosis, and necrosis. Am J Pathol 1995; 146: 3–15
   PubMed Web of Science ®Google Scholar
• Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1996; 75: 426–33
   Google Scholar
• Gottlieb R A, Gruoi D L, Zhu J Y, Engler R L. Preconditioning in rabbit cardiomyocytes. Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 1996; 97: 2391–8
   PubMed Web of Science ®Google Scholar
• Cheng W, Li B, Kajstura J, Li R. et al. Stretch-induced programmed myocyte cell death. J Clin Invest 1995; 96: 2247–59
   PubMed Web of Science ®Google Scholar
• Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996; 74: 86–107
   PubMed Web of Science ®Google Scholar
• Bardales R H, Hailey S, Xie S S, Schaefer R F, Hsu S M. In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 1996; 149: 821–9
   PubMedGoogle Scholar
• Quaini F, Cigola E, Sala R, et al. Apoptosis in the infarcted human heart. Basic Appl Myology 1996; 6: 241–9
   Google Scholar
• Saraste A, Pulkki K, Kallajoki M, Henriksson K, Parviainen M, Voipio-Pulkki L M. Apoptosis in human acute myocardial infarction. Circulation 1997; 95: 320–3
   PubMed Web of Science ®Google Scholar
• Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182–9
   PubMed Web of Science ®Google Scholar
• Saraste A, Voipio-Pulkki L M, Parvinen M, Pulkki K. Apoptosis in the heart. N Engl J Med 1997; 336: 1025–6
   PubMedGoogle Scholar
• Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131–41
   PubMed Web of Science ®Google Scholar
• Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995; 92: 1479–86
   PubMed Web of Science ®Google Scholar
• Nishigaki K, Minatoguchi S, Asano K, et al. Plasma levels of soluble Fas ligand, apoptosis signaling receptor molecule, in patients with congestive heart failure. Circulation 1996; 94(Suppl 1)1–32
   PubMedGoogle Scholar
• Scarabin P Y, Bara L, Ricard S, et al. Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 1993; 13: 886–91
   PubMed Web of Science ®Google Scholar
• Mendall M A, Patel P, Ballam L, Strachan D, Northfield T C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061–5
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Biasucci L M, Gallimore J R, et al. The prognostic value of C-reactive protein and serum amyloid a in severe unstable angina. N Engl J Med 1994; 331: 417–24
   PubMed Web of Science ®Google Scholar
• Turner D M, Grant S C, Lamb W R, et al. A genetic marker of high TNF-alpha production in heart transplant recipients. Transplantation 1995; 60: 1113–7
   PubMedGoogle Scholar